Glycididazole Sodium

甘氨双唑钠

Report date: 2022/02/21 15:10:34
NME

Base Information

Drug NameGlycididazole Sodium
Drug Alias NameSodium glycididazole希美纳CMNa
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRadiosensitizers
TargetsNot applicable
Therapy Area/IndicationsLung NeoplasmsHead and Neck NeoplasmsEsophageal Neoplasms
Global Approved IndicationsLung NeoplasmsHead and Neck NeoplasmsEsophageal Neoplasms
Approved Indications in ChinaLung NeoplasmsHead and Neck NeoplasmsEsophageal Neoplasms
Original Approved Country/TerritoryMainland China
Original Approved Date2002/11/29
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGuangzhou Lifetech Pharmaceutical Co LtdSecond Military Medical University Of Chinese People'S Liberation Army
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesGuangzhou Lifetech Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsHead and Neck NeoplasmsEsophageal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeL01
Related LinksN/A